Synapse

← Journal of Immunotherapy and Precision Oncology

Papers in Journal of Immunotherapy and Precision Oncology

Page 3 · newest first

  1. A Wolf in Sheep's Clothing: Systemic Immune Activation Post ImmunotherapyJournal of Immunotherapy and Precision Oncology · 2021
  2. Real-World Experiences of CAR T-Cell Therapy for Large B-Cell Lymphoma: How Similar Are They to the Prospective Studies?Journal of Immunotherapy and Precision Oncology · 2021
  3. Rare Blood Cancers in 2021: Importance of Continued Exchange of IdeasJournal of Immunotherapy and Precision Oncology · 2021
  4. Inflammation in Myeloid Malignancies: From Bench to BedsideJournal of Immunotherapy and Precision Oncology · 2021
  5. Novel Therapies in Myeloproliferative Neoplasms: Beyond JAK Inhibitor MonotherapyJournal of Immunotherapy and Precision Oncology · 2021
  6. Synchronized Tissue Acquisition Techniques for Novel Biomarker Discovery: Are You Ready to Waltz?Journal of Immunotherapy and Precision Oncology · 2021
  7. JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with MyelofibrosisJournal of Immunotherapy and Precision Oncology · 2021
  8. Chronic Myelomonocytic Leukemia: Hematopathology PerspectiveJournal of Immunotherapy and Precision Oncology · 2021
  9. Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint InhibitorsJournal of Immunotherapy and Precision Oncology · 2021
  10. Clinical Development of Colony-Stimulating Factor 1 Receptor (CSF1R) InhibitorsJournal of Immunotherapy and Precision Oncology · 2021
  11. Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensJournal of Immunotherapy and Precision Oncology · 2021
  12. First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced PneumonitisJournal of Immunotherapy and Precision Oncology · 2021
  13. Targeted Cancer Therapy and Its Ophthalmic Side Effects: A ReviewJournal of Immunotherapy and Precision Oncology · 2021
  14. Real-World Data on Liquid Biopsy Use in Non-Small Cell Lung Cancer in the Community SettingJournal of Immunotherapy and Precision Oncology · 2021
  15. Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?Journal of Immunotherapy and Precision Oncology · 2021
  16. Comprehensive Genomic Profiling-Guided Niraparib Treatment of Triple-Negative Breast Cancer in a Patient With Extensive Brain Metastasis: Case Report and Literature ReviewJournal of Immunotherapy and Precision Oncology · 2021
  17. Wilms' Tumor 1 (WT1): The Vaccine for CancerJournal of Immunotherapy and Precision Oncology · 2020
  18. The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in GliomasJournal of Immunotherapy and Precision Oncology · 2020
  19. Case Report: Metastatic Dedifferentiated Liposarcoma Presenting as Hypereosinophilia in an AdolescentJournal of Immunotherapy and Precision Oncology · 2020
  20. Role of Infliximab in Immune Checkpoint Inhibitor-Induced PneumonitisJournal of Immunotherapy and Precision Oncology · 2020
  21. Cancer Epigenomics and Beyond: Advancing the Precision Oncology ParadigmJournal of Immunotherapy and Precision Oncology · 2020
  22. Reactivation of Hepatitis B Virus Among Patients With Cancer Receiving ImmunotherapyJournal of Immunotherapy and Precision Oncology · 2020
  23. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical CancerJournal of Immunotherapy and Precision Oncology · 2020
  24. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated ArrhythmiasJournal of Immunotherapy and Precision Oncology · 2020
  25. Case Report: Sustained Complete Response to PI3K Inhibition in a Patient with Metastatic Breast Cancer Harboring PIK3CA , NF1 , and CDH1 MutationsJournal of Immunotherapy and Precision Oncology · 2020
  26. Repurposing Interleukin-6 Inhibitors to Combat COVID-19Journal of Immunotherapy and Precision Oncology · 2020
  27. When Molecular-Targeted Agents Meet Immunotherapy: The Opportunities for Soft Tissue SarcomaJournal of Immunotherapy and Precision Oncology · 2020
  28. Clinicopathologic Features and Whole Genome Sequencing of a Primary Osteosarcoma of the UterusJournal of Immunotherapy and Precision Oncology · 2020
  29. Bromodomain and Extra-Terminal (BET) Domain Protein Inhibitors for Solid Tumor CancersJournal of Immunotherapy and Precision Oncology · 2020
  30. Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging ParadigmsJournal of Immunotherapy and Precision Oncology · 2020
  31. Pneumocystis Infection in Two Patients Treated with Both Immune Checkpoint Inhibitor and CorticoidsJournal of Immunotherapy and Precision Oncology · 2020
  32. Review of Immunogenomics and the Role of Tumor Mutational Burden as a Biomarker for Immunotherapy ResponseJournal of Immunotherapy and Precision Oncology · 2019
  33. Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire SequencingJournal of Immunotherapy and Precision Oncology · 2019
  34. Review: The Impact of HIV Infection on Cancer Treatment with ImmunotherapyJournal of Immunotherapy and Precision Oncology · 2019
  35. Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting SystemJournal of Immunotherapy and Precision Oncology · 2019
  36. Immunotherapy Use in Patients with HIV and Non-Small-Cell Lung Cancer: Current DataJournal of Immunotherapy and Precision Oncology · 2019
  37. Kaposi's Sarcoma in the ImmunosuppressedJournal of Immunotherapy and Precision Oncology · 2019
  38. Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature ReviewJournal of Immunotherapy and Precision Oncology · 2019
  39. Tackling Immunotherapy Resistance: Developing Rational Combinations of Immunotherapy and Targeted DrugsJournal of Immunotherapy and Precision Oncology · 2019
  40. Extracellular Signal-Regulated Kinase (ERK) Inhibitors in Oncology Clinical TrialsJournal of Immunotherapy and Precision Oncology · 2019
  41. Toxic Epidermal Necrolysis During Cotherapy with Ipilimumab and NivolumabJournal of Immunotherapy and Precision Oncology · 2018
  42. Pyoderma Gangrenosum Following Initiation of Immune Checkpoint Inhibitor TherapyJournal of Immunotherapy and Precision Oncology · 2018
  43. Personalized Cancer Immunotherapy: Today’s Challenge and Tomorrow’s PromiseJournal of Immunotherapy and Precision Oncology · 2018
  44. Pneumonitis After Precision Oncology Therapies: A Concise ReviewJournal of Immunotherapy and Precision Oncology · 2018
  45. Understanding the Toxicity of Cancer Immunotherapies: Use of Patient-Reported OutcomesJournal of Immunotherapy and Precision Oncology · 2018
  46. Bronchiolitis Obliterans after Combination Immunotherapy with Pembrolizumab and IpilimumabJournal of Immunotherapy and Precision Oncology · 2018
  47. The Impact of Immune Checkpoint Inhibitor-Related Adverse Events and Their Immunosuppressive Treatment on Patients’ OutcomesJournal of Immunotherapy and Precision Oncology · 2018